Ask Scout

Ask about the market — sign in for answers about your own watchlist and alerts.

Educational only — not financial advice.

BCRX

BioCryst Pharmaceuticals, Inc.

NASDAQ · EQUITY

$8.02 -$0.27 (-3.26%)

Price · 10 years

Avg volume —

    RSI (14)

    P/E (TTM)

    MACD (12, 26, 9)

    A/D Line

    Members of Congress Trading BCRX

    In the last 12 months, 1 member of Congress disclosed buying BCRX, most recently Gil Cisneros (trade on Jul 10, 2026, disclosed Sep 4, 2026).

    Traded Member Action Amount Disclosed
    Jul 10, 2026 Gil Cisneros CA31 Bought shares $1K–$15K Sep 4, 2026
    Nov 13, 2025 Gil Cisneros CA31 Bought shares $1K–$15K Dec 15, 2025

    From House and Senate members' STOCK Act disclosures. See which members pick the best stocks on the Congress stock trading leaderboard.